Autophagosome

An **autophagosome** is a transient, double-membrane-bound vesicle formed within cells as part of the autophagy pathway[1][4][9]. It engulfs cytoplasmic material, including damaged organelles, misfolded proteins, and invading microorganisms, and delivers them to the lysosome for degradation and recycling[1][4][7][9]. Autophagosome formation is regulated by a complex network of autophagy-related (ATG) proteins and is essential for cellular homeostasis, stress adaptation, immune defense, and the selective removal of damaged or toxic cellular constituents[1][7][4][8]. Dysfunctions of autophagosome biogenesis and autophagy have been implicated in various conditions, including neurodegenerative diseases, cancers, infections, and metabolic disorders[1][4][5]. The presence of autophagosomes can be detected in cells by monitoring markers such as LC3-II[9]. **Key note:** The autophagosome is not a molecular therapeutic target (such as a receptor or enzyme), but rather a subcellular structure or organelle formed from the coordinated activity of many proteins[1][4][7]. Therefore, it is not directly druggable, and this entity is not itself an actionable pharmacological target; drugs generally affect autophagosome formation or clearance by acting on its regulatory proteins (e.g., mTOR, ULK1, PI3K complexes, ATG proteins), not the autophagosome structure per se[1][3][7][4]. Because "autophagosome" is a cellular structure and not a single molecular drug target, **is_target** is false and **is_incorrect** is true for the purpose of lists of canonical druggable receptor or enzyme targets.